Table 3.
Control group (n = 63) | Genotype‐guided group (n = 62) | P value | |
---|---|---|---|
Tacrolimus level range, n (%) | .021 | ||
Therapeutic | 15 (23.8) | 25 (40.3) | .048 |
Subtherapeutic | 31 (49.2) | 31 (50.0) | .93 |
Over‐therapeutic | 17 (27.0) | 6 (9.7) | .013 |
Control group (n = 63) | Genotype‐guided group (n = 62) | P value | |
---|---|---|---|
Tacrolimus level range, n (%) | .021 | ||
Therapeutic | 15 (23.8) | 25 (40.3) | .048 |
Subtherapeutic | 31 (49.2) | 31 (50.0) | .93 |
Over‐therapeutic | 17 (27.0) | 6 (9.7) | .013 |